Skip to main content

Advertisement

SpringerLink
Log in

BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.

    Article  CAS  Google Scholar 

  2. Flamant S, Richie W, Guilhot J, Hols J, Bonnet ML, Chomel JC et al. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 2010; 95: 1325–1333.

    Article  CAS  Google Scholar 

  3. Agirre X, Velasco A, San José-Enériz E, Garate L, Bandrés E, Cordeu L et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 2008; 6: 1830–1840.

    Article  CAS  Google Scholar 

  4. Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010; 140: 652–665.

    Article  CAS  Google Scholar 

  5. Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y et al. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007; 129: 617–631.

    Article  CAS  Google Scholar 

  6. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005; 123: 819–831.

    Article  CAS  Google Scholar 

  7. Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K et al. BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2. Nat Genet 2002; 30: 48–58.

    Article  CAS  Google Scholar 

  8. Pulikkan JA, Dengler V, Peramangalam PS, Zada AAP, Muller-Tidow C, Bohlander SK et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010; 115: 1768–1778.

    Article  CAS  Google Scholar 

  9. Fazi F, Racanicchi S, Zardo G, Starnes LM, Mancini M, Travaglini L et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007; 12: 457–466.

    Article  CAS  Google Scholar 

  10. Baek D, Villén C, Shin C, Camargo FD, Gygi SP, Bartel DP . The impact of microRNAs on protein output. Nature 2008; 455: 64–71.

    Article  CAS  Google Scholar 

  11. Guo H, Ingolia NT, Weissman JS, Bartel DP . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835–840.

    Article  CAS  Google Scholar 

  12. Stehling-Sun S, Dade J, Nutt SL, DeKoter RP, Camargo FD . Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c. Nat Immunol 2009; 10: 289–296.

    Article  CAS  Google Scholar 

  13. Xue Y, Zhou Y, Wu T, Zhu T, Ji X, Kwon Y et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell 2009; 36: 996–1006.

    Article  CAS  Google Scholar 

  14. Chen CZ, Li L, Lodish HF, Bartel DP . MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83–86.

    Article  CAS  Google Scholar 

  15. Salesse S, Dylla SJ, Verfaillie CM . p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells. Leukemia 2004; 18: 727–733.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Clara Nervi, Department of Histology and Medical Embryology, University La Sapienza, Rome, Italy, for the lentiviral vector construct carrying miR-223. We thank Dr Eugene Makeyev, School of Biological Sciences, Nanyang Technological University, Singapore for PTBP2 3′ UTR luciferase construct. We also thank Professor Catherine M Verfaillie, KU Leuven, Belgium, for her critical review of the manuscript. We also thank Ms Nivedita Kuila and Mr Pulak Mohanty for their assistance. This work was supported by the Institutional core grant. SA is supported by fellowship from the Council of Scientific and Industrial Research (CSIR), India. SS is supported by fellowship from the University Grants Commission (UGC), India.

Author information

Authors and Affiliations

  1. Institute of Life Sciences, Bhubaneswar, India

    S Agatheeswaran, S Singh & S Chakraborty

  2. Sparsh Hospital and Critical Care, Bhubaneswar, India

    S Biswas & G Biswas

  3. Department of Clinical Haematology, SCB Medical College, Cuttack, India

    N Chandra Pattnayak

Authors
  1. S Agatheeswaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Biswas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Biswas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Chandra Pattnayak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Chakraborty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Chakraborty.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agatheeswaran, S., Singh, S., Biswas, S. et al. BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia. Leukemia 27, 1578–1580 (2013). https://doi.org/10.1038/leu.2012.339

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.339

  • Springer Nature Limited

This article is cited by

Search

Navigation